Diagnostic value of inflammatory indexes combined with myocardial enzymes for aneurysmal subarachnoid hemorrhage in patients with intracranial aneurysms

炎症指标联合心肌酶对颅内动脉瘤患者动脉瘤性蛛网膜下腔出血的诊断价值

阅读:2

Abstract

OBJECTIVE: The purpose of the study is to evaluate the diagnostic ability of inflammatory indexes alone and in combination with myocardial enzymes in the prediction of aneurysmal subarachnoid hemorrhage (aSAH). MATERIALS AND METHODS: This is a 1:1 age- and sex-matched case-control study in Tianjin, China. 226 patients aged > 18 years divided into aSAH group and unruptured intracranial aneurysm (UIA) group. Logistic regression models assessed associations between inflammatory indexes/myocardial enzymes and aSAH. Receiver operating characteristic (ROC) curves evaluated their sensitivity/specificity for aSAH. RESULTS: Higher neutrophil-to-lymphocyte ratio (NLR) (OR: 1.130, 95 % CI: 1.074, 1.188), monocyte-to-lymphocyte ratio (MLR) (OR: 11.144, 95 % CI: 3.071, 40.437), platelet-to-lymphocyte ratio (PLR) (OR: 1.006, 95 % CI: 1.003, 1.008), systemic immune-inflammatory index (SII) (OR: 1.000, 95 % CI: 1.000, 1.001) and systemic inflammation response index (SIRI) (OR: 1.228, 95 % CI: 1.112, 1.357), myocardial enzymes lactate dehydrogenase (LDH) (OR: 1.008, 95 % CI: 1.003, 1.014), creatine kinase (CK) (OR: 1.002, 95 % CI: 1.000, 1.004), and α-hydroxybutyrate dehydrogenase (HBDH) (OR: 1.010, 95 % CI: 1.002, 1.018) were all significantly associated with the presence of aSAH. The diagnostic value of inflammatory indexes (NLR-PLR-MLR-SII-SIRI) and myocardial enzymes (LDH-HBDH-CK-CKMB) gave an AUC of 0.771 and 0.662 (all P-value < 0.001), respectively. Combined use of these indexes achieved an AUC of 0.755 (P-value< 0.001), suggesting potential value as a diagnostic adjunct for aSAH. CONCLUSIONS: The results suggest that higher inflammatory indexes and myocardial enzymes were associated with the presence of aSAH. The combination of inflammatory indexes and myocardial enzymes may serve as a diagnostic complement for identifying aSAH in patients with IA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。